The global Ultrasound Scalpel market outlook through 2030 remains highly attractive, underpinned by a mid-teens revenue CAGR and widening reimbursement for minimally-invasive ultrasonic dissection. Competitive intensity is moderate but rising: three platform leaders control 55% share, yet a second wave of Asian and specialty OEMs is compressing price points by 6–8% annually. Long-term demand will outpace supply as procedural penetration in ambulatory surgery centers and emerging markets doubles, creating a 4–5% installed-base shortfall after 2027. Innovation is migrating toward disposable micro-blades with embedded sensors for real-time tissue feedback, opening a $1bn+ whitespace. On the risk ledger, reimbursement erosion in the U.S., potential nickel-titanium alloy shortages, and a looming EU MDR regulatory bottleneck could stall momentum. Decision-makers should prioritize M&A to secure sensor IP, lock in alloy supply, and expand ASPAC manufacturing capacity to stay ahead of tightening margin pressure.